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Abstract
Purpose Ventral abdominal wall hernias are common and
repair is frequently associated with complications and
recurrence. Although non-crosslinked intact porcine-
derived acellular dermal matrix (PADM) has been used
successfully in the repair of complex ventral hernias, there
is currently no consensus regarding the type of mesh and
surgical techniques to use in these patients. This report
provides added support for PADM use in complex ventral
hernias.
Methods In a consecutive series of adult patients
(2008–2011), complex ventral abdominal wall hernias
(primary and incisional) were repaired with PADM by a
single surgeon. Patient comorbidities, repair procedures,
and postoperative recovery, recurrence, and complications
were noted.
Results Forty-four patients (mean age, 57.5 years)
underwent 45 single-stage ventral abdominal wall hernia
repairs (3 primary; 42 incisional). Previously placed syn-
thetic mesh was removed in 17 cases. In 40 cases, primary
fascial closure was achieved; in 5 cases, PADM was used
as a bridge. Vacuum-assisted closure (VAC) was used for
38/45 cases: 19 closed incisions, 16 cases using the
‘‘French fry’’ technique, and 3 cases with open incisions.
Mean hospital stay was 8.2 days (range, 3–32) and mean
follow-up was 17 months (range, 1–48). There were 4
(8.9 %) hernia recurrences, 3 requiring additional repair
and 1 requiring PADM explantation. There were 3 (6.7 %)
skin dehiscences, 4 (8.9 %) deep wound infections
requiring drainage, and 5 (11.1 %) seromas (4 self-limited,
1 requiring drainage).
Conclusions Non-crosslinked intact PADM yielded
favorable early outcomes when used to repair complex
ventral abdominal wall hernias in high-risk patients.
Keywords Ventral abdominal wall hernias 
Non-crosslinked intact porcine-derived acellular
dermal matrix  Vacuum-assisted closure  Synthetic
mesh  Biologic acellular dermal matrix  Strattice
Introduction
The ventral abdominal wall is second to the inguinal region
for the most common types of abdominal hernia and may
lead to life-threatening complications [1]. Ventral inci-
sional hernias are typically seen as postoperative compli-
cations of abdominal surgery, with a reported incidence of
11 to 19 % in patients undergoing laparotomy [2, 3]. Risk
factors for incisional hernia include obesity, diabetes,
emergency surgery, postoperative wound dehiscence,
smoking, and postoperative wound infection [4–6].
To help surgeons stratify patient risk of developing
postoperative complications and promote improved patient
selection for different surgical repair approaches, the
Ventral Hernia Working Group (VHWG) proposed a four-
level surgical-site occurrence risk grading system (Fig. 1)
[7]. For healthy patients without significant comorbidities
(Grade 1), prosthetic mesh is recommended (vs suture
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repair alone) for reducing recurrence [7, 8]. Use of a bio-
logic matrix rather than synthetic mesh should be consid-
ered in patients with comorbidities (Grade 2) because of
their increased risk of surgical-site occurrences [7]. For
patients with a high risk of surgical-site occurrences due to
contamination (Grade 3) or infection (Grade 4), biologic
matrix repair is preferable to synthetic mesh repair for
reducing recurrence [7, 9], though prospective, well-con-
trolled trials comparing these mesh types are lacking.
Although synthetic mesh continues to be used in
abdominal wall hernia repair, it is associated with post-
operative complications including intestinal obstruction,
fistula formation, extrusion, and infection [7]. Biologic
matrices (such as ADM) have become more commonly
used as effective alternatives to synthetic mesh in the set-
ting of ventral herniorrhaphy. A non-crosslinked intact
porcine-derived ADM (PADM; StratticeTM Reconstructive
Tissue Matrix, LifeCell Corp., Branchburg, NJ, USA) is
designed to perform as a surgical mesh for soft-tissue
repair while serving as a scaffold for the rapid ingrowth of
host cells, collagen, and blood vessels [10].
The objective of the current retrospective cohort study is
to describe and evaluate repair procedures, postoperative
complications, and short-term outcomes with PADM in a
series of patients with complex primary and incisional
ventral hernias. For the purposes of this study, a VHWG




This was an Institutional Review Board-approved retro-
spective cohort study of all consecutive adult patients
undergoing single-stage complex ventral herniorrhaphy
(primary and incisional) with PADM by the senior author
(O.G.) between 2008 and 2011. Details on patient
demographics and comorbidities, history related to the
hernias, and hernia characteristics were noted.
Surgical repair procedures
Surgical repair procedures were largely determined by the
individual patient’s condition and anatomic findings.
Components separation was performed when primary fas-
cial closure could not otherwise be achieved. Muscle and
fascia repair was performed with #1 Prolene or polydi-
oxanone (PDS; Ethicon, Inc., Somerville, NJ, USA)
sutures. PADM was preferably used in the intraperitoneal
or retrorectus position to reinforce the repairs, and was only
used as a bridge when fascial closure could not be
achieved. PADM was secured into position with transfas-
cial #1 Prolene or PDS sutures. Blake drains (size 19
French) were placed in most cases and secured to bulb
suction. Wound closure, when performed, was done with
sutures of appropriate type and size. Vacuum-assisted
closure (VAC) was applied to reduce wound tension and
promote healing. In some cases involving a ‘‘French fry’’
technique, strips of white foam 2 cm in width were inserted
into portals of the incision (Fig. 2), after which a wound
VAC was placed over the entire incision using black foam.
Postoperative management
Surgical drains were continued postoperatively until output
was \30 cc/day for 2 consecutive days. Antibiotics were
continued as needed for patients with infection or gross
contamination. Pain management included epidural cathe-
ter or patient-controlled analgesia and then oral opioids.
Postoperative assessments
All patients were scheduled for follow-up office visits at 2
and 6 weeks and then yearly to address concerns, adverse
events, or complications. Patients were monitored for any
recurrences based on clinical examination in the office, by
Fig. 1 Ventral Hernia Working
Group (VHWG) hernia grading
system. Reproduced from
Breuing et al. [7] 2010, with
permission from Elsevier
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The demographic and clinical characteristics of patients are
summarized in Table 1. Mean age was 57.5 years (range,
34–80) and mean body mass index (BMI) was 36.7 kg/m2
(range, 21–65). The majority of procedures (n = 29) were
performed in female patients. A total of 44 patients
underwent 45 procedures (‘‘cases’’); 1 patient underwent 2
unrelated procedures and was considered as 2 separate
cases. She was initially treated for multisystem organ
failure and fecal peritonitis (Grade 4 hernia); the defect was
bridged with PADM. Two years later, she presented with a
Grade 3 hernia, which was treated with components sepa-
ration and PADM underlay.
Preoperative clinical characteristics
Three cases were primary hernias and 42 were incisional
hernias (Table 1). Of the incisional hernias, 30 cases were
following midline laparotomy, 8 were at midline and ost-
omy sites following laparotomy with ostomy takedown, 3
were following transverse rectus abdominis myocutaneous
(TRAM) flap procedures, and 1 was at a right subcostal
incision site. No cases qualified as VHWG Grade 1 (low
Fig. 2 Intraoperative photographs: a components separation;
b PADM underlay using transfascial sutures; c completion of the
underlay PADM placement; d completion of midline fascial closure;
e ‘‘French fry’’ technique with 2 portals with white foam; f black
foam placed over entire incision line; PADM non-crosslinked intact
porcine-derived acellular dermal matrix
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risk), and the mean grade was 3. Comorbidities included
history of abdominal wall infection (n = 33), obesity
(BMI [ 30 kg/m2; n = 27), chronic obstructive pulmon-
ary disease (COPD)/emphysema (n = 14), malnutrition
(n = 12), hypertension (n = 11), diabetes mellitus
(n = 11), and history of methicillin-resistant Staphylo-
coccus aureus (MRSA) infection (n = 10). Six patients
were obese and had malnutrition preoperatively. Four
patients had a history of prior mesh removal (none infec-
ted), 3 of which were following TRAM flap procedures by
another surgeon.
Operative techniques
Surgical details are summarized in Table 2. PADM was
successfully placed in 45 cases using either intraperitoneal
or retrorectus insertion; sheet sizes ranged from 6 9 16 cm
to 20 9 30 cm. In 40 cases, primary fascial closure was
achieved in equal proportions of cases with or without
components separation (Table 2; Fig. 2). PADM was used
as a bridge in five cases when fascial closure could not be
achieved, three of which involved components separation.
Of the five bridged cases, three had a subsequent hernia
recurrence as described below.
Previously placed synthetic mesh was removed at the
time of surgery in 17 cases. Mean number of drains placed
per patient was 3 (median, 4; range, 0–5). Wound VAC
(Kinetic Concepts, Inc., San Antonio, TX, USA) was used
in 38 of the 45 patient cases: 19 cases with closed incisions,
16 cases with a ‘‘French fry’’ technique, and 3 cases with
open wounds; 7 cases did not require VAC. Concurrent
surgical procedures performed included panniculectomy
(n = 10) and stoma takedown (n = 6). The mean length of
surgery was 192 min (median, 170; range, 58–447).
Postoperative course
Patients were followed for a mean of 17 months (median,
12; range, 1–48). Thirty-seven of the 45 cases included in




















History of abdominal wall infection 33 (73)
History of MRSA abdominal wall infection 10 (22)
COPD/emphysema 14 (31)
Malnutrition/low preoperative serum albumin 12 (27)
Diabetes mellitus 11 (25)
Hypertension 11 (25)
Smoking 9 (20)
Stoma present 6 (13)
Renal failure 2 (4)
Therapeutic use of corticosteroids 2 (4)
Chronic panniculitis 2 (4)
History of coronary artery bypass graft 2 (4)
Breast cancer 2 (4)
Congestive heart failure 2 (4)
Atrial fibrillation 2 (4)
Crohn’s disease 2 (4)
Thoracic aneurysm 2 (4)
Other 23 (51)
a One patient presented 2 years after initial treatment. This patient
had two separate procedures and was considered as two separate cases
b See Fig. 1 for explanation of VHWG grades
BMI body mass index, COPD chronic obstructive pulmonary disease,
MRSA methicillin-resistant S. aureus
Table 2 Surgical repair
Procedural information Frequency, n (%)
Synthetic mesh removed
Infected 11 (24)
Non-infected total 6 (13)
Total 17 (38)
Successful fascial closure
Components separated 20 (44)
Components not separated 20 (44)
Total 40 (89)
Failed fascial closure; PADM used as a bridge
Components separated 3 (7)






PADM non-crosslinked intact porcine-derived acellular dermal matrix
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the analysis had clinical follow-up of C6 weeks. Of the 25
cases involving patients classified as VHWG Grade 3 risk,
21 had clinical follow-up of C6 weeks; all 11 Grade 4
cases had follow-up of C6 weeks. A total of 14 cases
required postoperative antibiotics for infection, including
11 with preoperative mesh infections and 4 with postop-
erative deep infections. Antibiotic regimens most often
included vancomycin, piperacillin/tazobactam, or ertape-
nem. Postoperative VAC was applied for a median of
7 days and drains were removed after a median of 2 weeks.
The mean length of hospital stay was 8 days (median, 7;
range, 3–32). Figure 3 shows a typical preoperative
abdominal profile and postoperative results for one of the
patients.
Postoperative assessments
Postoperative complications were documented. There were
3 (6.7 %) skin dehiscences (all treated with local wound
care), 4 (8.9 %) deep wound infections (all requiring open
drainage), and 5 (11.1 %) seromas (4 self-limited and 1
requiring drainage). All three events of skin dehiscence
occurred in patients with Grade 3 hernias who had suc-
cessful midline closure achieved with intraperitoneal
placement of PADM. Regarding the four patients who
experienced deep wound infections, the first patient was a
43-year-old obese female (BMI, 54 kg/m2), classified as
VHWG Grade 3 risk for postsurgical complications, with a
history of postoperative wound infections. She underwent a
Fig. 3 a, b Large midline incisional hernia and parastomal hernia;
c following completion of ileostomy takedown with ileocolic
anastomosis, bilateral components separation with repair of incisional
hernia with PADM, and wound closure using the ‘‘French fry’’
technique; d, e 2 years after surgery
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panniculectomy and removal of a previously placed Kugel
mesh, followed by hernia repair with PADM and VAC
using the ‘‘French fry’’ technique. Her wound infection was
secondary to a foreign body (black foam fibers left in the
wound). There has been no hernia recurrence as of
38 months of follow-up. The second patient with a deep
wound infection was a 63-year-old obese female (BMI,
58 kg/m2), classified as VHWG Grade 3 risk, with history
of COPD and malnutrition. PADM was placed as a bridge
in this patient, with VAC over a closed incision. She
developed a wound infection and underwent open drainage
in the operating room. The wound healed by secondary
intention with a VAC over the exposed PADM. She
developed a hernia recurrence at 6 months and underwent
repair of her recurrent hernia with synthetic mesh used as a
bridge, and had no recurrence through 2 years of follow-up
after placement of the synthetic mesh. The third patient
with a deep wound infection was a 67-year-old obese male
(BMI, 40 kg/m2) classified as VHWG Grade 3 risk. He had
a history of postoperative wound infections and underwent
concurrent colostomy takedown, diverting loop ileostomy,
and midline incisional hernia repair with PADM; VAC was
placed on the closed incision. He developed a wound
infection due to leakage of enteric ostomy contents into the
wound. Open drainage was performed and the wound
healed by secondary intention with VAC on the open
wound. The PADM was an underlay and was not visually
exposed. This patient has had no recurrence at 13 months
of follow-up. The fourth patient with a deep wound
infection was a 68-year-old female (BMI, 26 kg/m2) with
malnutrition and history of postoperative wound infections.
She had an infected Kugel mesh removed and the defect
repaired with PADM in a retrorectus fashion. A VAC was
placed on the closed incision. She developed a wound
infection, which was treated with open drainage. Interest-
ingly, the abscess was in between the PADM and posterior
sheath. The PADM was vascularized and completely
integrated with the rectus muscle. A drain was placed
behind the PADM, the fascia was closed, and VAC was
placed on the open wound. She has not experienced a
hernia recurrence at 1 year postoperatively. Of the five
patients who experienced seromas, four patients had Grade
3 hernias and one had a Grade 4 hernia; two patients had a
BMI \ 30 kg/m2, one had a BMI of 30 kg/m2, and two had
a BMI [ 40 kg/m2. Successful midline closure was
achieved in all five of these patients, of whom four had
intraperitoneal placement of PADM while one had retro-
rectus placement of PADM. No seroma patient has expe-
rienced a recurrent hernia.
Hernias recurred in 4 of the 45 cases (8.9 %) overall,
and 4 of 37 (11.8 %) cases with longer than 6 weeks of
follow-up. All patients who did not return for the yearly
follow-up underwent a telephone interview and no recur-
rences were reported. The follow-up time in the current
study reflected only those patients who had clinical follow-
up comprising physical examination by the senior author.
Hernia recurrences occurred in patients who were at high
risk for complications. One recurrence occurred in a Grade
4 obese patient (BMI, 30 kg/m2) who presented with small
bowel injury and fecal peritonitis following laparoscopic
incisional hernia repair with synthetic mesh. She under-
went abdominal washout, repair of the small bowel enter-
otomy, removal of the fecal-contaminated mesh, and repair
of the chronic 20-cm hernia defect with intraperitoneal
placement of PADM as a bridge for closure. A VAC was
placed using the ‘‘French fry’’ technique after decontami-
nation, and the patient recovered fully within 6 weeks.
Unfortunately, she developed a recurrence at 3 months.
Two years later, she presented with a symptomatic Grade 3
hernia and underwent bilateral components separation and
PADM placement in an underlay fashion with midline
rectus muscle closure. She has had no recurrence at 2 years
following this operation. The second recurrence occurred
in a Grade 2 patient who had a failed mesh repair and
multiple comorbidities, including morbid obesity (BMI,
59 kg/m2) and a history of diabetes mellitus, COPD, and
current smoking. She underwent removal of failed mesh,
repair of the recurrent hernia with PADM in an intraperi-
toneal position, and a fleur-de-lis panniculectomy. She
developed a recurrence 9 months after the initial repair.
She was reoperated on for the recurrence and synthetic
mesh was placed. She has experienced no recurrence
through 1 year of follow-up. Another high-risk patient
(BMI, 59 kg/m2, history of COPD, Grade 3 hernia) had
hernia recurrence 6 months following a 15-cm bridged
repair with PADM complicated by a colon enterotomy
during adhesiolysis. She had a wound infection and the
wound healed with VAC over the PADM. Eventually, she
underwent surgical repair for the hernia recurrence with
synthetic mesh placed as a bridge. The fourth recurrence
occurred in a patient who had Grade 4 hernia and was
morbidly obese (BMI, 65 kg/m2) with a history of diabetes,
COPD, and a large untreated hernia. This patient was in an
automobile accident and suffered a lap belt injury with
resultant enterocutaneous fistula and full-thickness necrosis
of the abdominal wall including the underlying small
bowel and colon. She underwent an ileocolectomy and
bridged repair with PADM, but within 1 week after surgery
she developed an anastomotic leak and recurrent entero-
cutaneous fistula with loss of the PADM. Her recurrent
hernia has been managed without further surgical inter-
vention. Preoperative photographs of the four patients who
subsequently had hernia recurrence are shown in Online
Resource 1.
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Discussion
The senior author performed 529 herniorrhaphies with
mesh during the study time period. Of those, 235 were
ventral/incisional hernias, 219 inguinal, and 75 umbilical.
Synthetic mesh was used in all but 45 ventral/incisional
hernia repairs. Thus, synthetic mesh also plays a role in this
surgical practice, including cases involving Grade 1 and
even Grade 2 patients. The senior author is of the opinion
that the only absolute indication for biologic matrix use in
a VHWG Grade 2 risk patient is immunosuppression. If a
patient presents with 3–4 risk factors, the senior author is
more likely to use PADM. Synthetic mesh is sometimes
used in healthy Grade 3 patients (i.e., previous wound
infection) with good results most of the time. Nonetheless,
Grade 3 patients with multiple comorbidities, previous
wound infection, multiple previous failed synthetic mesh
repairs, and/or previous mesh infections should receive a
biologic matrix, not a synthetic mesh. Interestingly, of the
45 patients included in this report, 11 (24 %) had infected
synthetic mesh removed at the time of surgery and 6 had
non-infected synthetic mesh removed at the time of sur-
gery. This represents a total of 17 patients (38 %) in the
population studied who had synthetic mesh removed either
for infection or recurrence at the time of surgery, illus-
trating that synthetic mesh does carry risk of complications.
In the subset of 11 patients who had infected mesh
removed, a simultaneous single-stage repair was performed
with PADM with 2 recurrences at an average 2-year fol-
low-up (12–41 months). Both recurrences occurred fol-
lowing bridged repairs with fecal contamination in patients
classified as American Society of Anesthesiologists (ASA)
physical status category 4 (life-threatening systemic
disease).
This is another demonstration in a growing published
experience with the use of non-crosslinked intact PADM
for hernia repair. All patients presented with complex
ventral abdominal wall hernias, comorbidities, and risk
factors for postoperative complications. During a mean of
17 months of postoperative follow-up, surgical outcomes
were observed marked by rates of hernia recurrence
(8.9 %), seroma formation (11.1 %), and wound infection
(8.9 %) consistent with prior published reports in similar
patients in whom a biologic matrix was used [11–16]. In
addition, of the 41 patients with no recurrent hernia, no
patient has experienced bulging.
The major challenges posed in the treatment of patients
with complex ventral hernias include a history of prior
herniorrhaphies (each of which increases the risk of future
recurrence) and risk factors that compromise wound heal-
ing [5, 6]. To address some of these challenges, human or
animal-derived (porcine or bovine) mesh products have
been introduced over the last decade. Large, well-
controlled, prospective clinical trials comparing mesh types
are lacking and there is currently no consensus regarding
the best materials to use in complex abdominal wall hernia
patients. Unresolved questions regarding biologic mesh
remain, including identification of high-risk patients, opti-
mal surgical techniques, and long-term durability and
safety.
Among the available biologic mesh products, PADM
has been reported to perform well. In the current investi-
gation, hernia recurrence was seen in four (8.9 %) cases, all
of which involved high-risk patients with multiple
comorbidities, including concurrent COPD and morbid
obesity in three of the four. This compares favorably to the
recurrence rate (41 %) seen in a similar study of patients
who underwent repair using human-derived ADM [17].
The low recurrence rate seen currently is similar to that
observed in a prospective, multicenter, observational study
of 85 patients undergoing single-stage repair of an infected
or contaminated abdominal incisional hernia. In that study,
Itani et al. [15] found that PADM facilitated single-stage
reconstruction in 80 % of patients; at 12 months, no
patients required mesh explantation.
In this study, there were a total of five cases for which
PADM was placed as a bridge; three of these patients
experienced recurrence within a year. It should be noted
that patients in two of these cases had VHWG Grade 4 risk
for postsurgical complications. They both had frank fecal
contamination at the time of surgery and had grossly
infected previously placed mesh. Bridged placement of
PADM was chosen as a lifesaving measure. The third
bridge failure occurred in a woman with a BMI of 60 kg/
m2 who had a colon enterotomy during lysis of adhesions
during her hernia repair. The use of synthetic mesh was
contraindicated in all three of these very high-risk cases.
Previously published retrospective cohort studies have
also provided support for PADM as an appropriate choice
for complex ventral herniorrhaphy [13, 14]. Most recently,
Patel et al. [13] conducted a retrospective cohort study in
which PADM was used for the primary repair of complex
ventral hernias (majority of patients were VHWG Grade 2).
No hernia recurrences were observed over a mean follow-
up period of 474 days. The most common complications
were related to skin necrosis (22 %); other complications,
such as seroma (7.3 %) and wound dehiscence (7.3 %)
were observed. The present set of patients also experienced
successful outcomes, despite presenting as higher-risk
patients (mean VHWG Grade 3) compared with the
patients in the study by Patel et al.
The clinical advantages of biologic mesh may be related
to its ability to serve as a biologic scaffold. Unlike syn-
thetic mesh, which tends to become encapsulated with scar
tissue, biologic mesh allows revascularization and cellular
repopulation, eventually becoming integrated into host
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tissue. Clinically, PADM has been shown to focally inte-
grate well into host tissue with no adverse effects [18]. In
one animal study, both human ADM and PADM became
infiltrated with host cells and blood vessels within 4 weeks
and had good musculofascia-mesh interface strength [19],
which may help to prevent hernia recurrence. Importantly,
none of the mesh implantations in this animal study
showed signs of bowel adhesion formation or infection
[19]. Longer-term preclinical studies are needed to describe
how biologic mesh strength changes over time as continued
tissue remodeling takes place.
The use of a wound VAC in these patients deserves
attention. Incisional negative pressure wound therapy
(NPWT) following abdominal wall reconstruction and
panniculectomy has been shown to significantly improve
wound complication rates compared with the use of con-
ventional dressings (22 vs 63 %, respectively) [20]. Fur-
thermore, a second study showed similar results in
decreasing wound complication rates following abdominal
wall reconstruction (18 vs 55 %, respectively) [21]. In the
current study, 19 patients (15 %) had incisional NPWT
with 3 deep wound infections. The ‘‘French fry’’ technique
was used in 16 patients, with one (6 %) postoperative deep
wound infection. This technique may prove to be effective
in patients with high-risk wounds by reducing tension on
the incision line, eliminating fluid from deep wound
spaces, obliterating the deep wound space, increasing
periwound perfusion, and reducing edema within the skin
flaps. Currently in our practice, all patients with VHWG
Grade 2 risk have NPWT applied to the closed incision
following abdominal wall reconstruction. The ‘‘French
fry’’ technique is utilized in Grade 2 patients undergoing
concurrent panniculectomy to control the deep wound
space in this morbidly obese population. In addition, this
technique is preferred in Grade 3 patients who have con-
tamination in the form of enteric contents spillage, intra-
abdominal abscess, or removal of infected synthetic mesh,
as these patients are at high risk for postoperative wound
complications and subsequent hernia repair failure.
There is a lack of consensus regarding the most appro-
priate prosthetic material for patients classified as having
VHWG Grade 2 risk; our study included nine patients with
Grade 2 risk. The decision to use a biologic matrix for
surgical reconstruction in these cases was based on our
assessment of each patient’s risk profile derived from rel-
evant surgical and medical history in addition to specific
VHWG criteria (Table 1) for each individual. Of the nine
VHWG Grade 2 patients, all had multiple comorbidities,
seven had severe systemic disease (ASA physical classifi-
cation of 3 or 4), and the other two required removal of a
previously placed mesh.
Several limitations of this study deserve mention. The
study was retrospective, observational, and did not include
a comparative group. The present analysis was not
designed to compare clean versus dirty/contaminated
groups; outcomes based on such a comparison would be
interesting. Although the literature is replete with case
reports, larger-scale and longer-term studies evaluating
outcomes with PADM versus synthetic mesh are needed to
characterize differences regarding postoperative compli-
cations (including pain), quality of life, and costs. There is
a clear need for additional research to determine costs
associated with complex ventral herniorrhaphies. Such
costs would presumably be higher than those for less-
complicated cases (particularly costs associated with length
of stay, wound care, and recurrence rates). The postoper-
ative impact on activities of daily living and societal costs
(disability, lost productivity, etc.) could also be estimated.
The present study highlights the potential for treating
complex ventral hernias in a community hospital setting
rather than in a tertiary care center. Despite the fact that
many of the patients in this study presented with complex
ventral hernias, infection, and comorbidities, nearly all
patients had a successful recovery, with only one patient
requiring PADM explantation due to factors unrelated to
the herniorrhaphy. Several variables are critical to this
level of success, including advanced surgical techniques,
implantation of a biologic rather than a synthetic mesh, and
innovative postoperative wound care. All of these resour-
ces can be made available at the community level, making
it possible for patients with complex ventral hernias to be
treated without the need for referral to a university-based
hospital.
Conclusions
Non-crosslinked intact PADM contributes to favorable
early outcomes in complex ventral abdominal wall herni-
orrhaphy. Long-term studies are needed to elucidate out-
comes with PADM relative to synthetic and other biologic
mesh products.
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